ANTONIE D. KLINE, M.D.

Director, Pediatric Genetics

Dr. Kline received her M.D. degree from Jefferson Medical College, Philadelphia, PA. Her residency training was in the Department of Pediatrics, Sinai Hospital, Baltimore, MD, where she was one of the chief residents. She obtained her postdoctoral training in Medical Genetics at Jefferson Medical College, Philadelphia, PA, and in Clinical Cytogenetics at the Kennedy Krieger Institute of the Johns Hopkins University School of Medicine, Baltimore, MD.

In addition to her appointment at GBMC, Dr. KIine is Instructor in Pediatrics at the Johns Hopkins University School of Medicine and is on the Medical Staff of the University of Maryland School of Medicine. She has held a faculty appointment as Assistant Professor at the University of Vermont Medical School.

From 1993-1995, Dr. Kline was Director of the Division of Pediatric Genetics at the Maine Medical Center, Portland, ME, and the Assistant Director of Clinical Genetics at the Foundation for Blood Research, Scarborough, ME. In 1995, she joined the Department of Pediatrics at Sinai Hospital of Baltimore as the Director of the Division of Clinical Genetics.

 Dr. Kline is a Diplomate of the American Board of Pediatrics and the American Board of Medical Genetics, certified in clinical genetics, clinical cytogenetics, and clinical molecular genetics. She is also a Fellow of the American Academy of Pediatrics and a Founding Fellow of the American College of Medical Genetics.

She is the Medical Director of the Cornelia de Lange Syndrome Foundation, where she has been a member of the Scientific Advisory Committee for 12 years. She is also on the Professional Advisory Board of the 5p- Society. She is the author of more than 30 scientific articles, book chapters and abstracts regarding various aspects of genetic syndromes in newborns and children, as well as a member of the board of reviewing editors for the National Organization for Rare Disorders' Physicians Guide to Rare Diseases.
 
Her areas of expertise include evaluation of and genetic counseling for multiple birth defects and/or developmental issues, as well as correlation and interpretation of cytogenetic changes in a clinical setting.

back